Erratum: Dopamine and serotonin metabolism in response to chronic administration of fluvoxamine and haloperidol combined treatment (Journal of Neural Transmission (1) DOI: 10.1007/s00702-007-0753-1);Dopamine and serotonin metabolism in response to chronic administration of fluvoxamine and haloperidol combined treatment

Journal of Neural Transmission

Volumn 114, Issue 11, 2007, Pages 1443-1454

  Chertkow, Y ^a   Weinreb, O ^a   Youdim, M B H ^a   Silver, H ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

Clozapine; Dopamine; Fluvoxamine; Haloperidol; Schizophrenia; Serotonin

Indexed keywords

CLOZAPINE; DOPAMINE; FLUVOXAMINE; HALOPERIDOL; SEROTONIN; SEROTONIN UPTAKE INHIBITOR; TYROSINE 3 MONOOXYGENASE;

ARTICLE; BRAIN REGION; CONTROLLED STUDY; DOPAMINE METABOLISM; DRUG EFFECT; DRUG MECHANISM; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SCANNING ELECTRON MICROSCOPY; SEROTONIN METABOLISM;

EID: 34548113932     PISSN: 03009564     EISSN: 14351463     Source Type: Journal    
DOI: 10.1007/s00702-007-0782-9     Document Type: Erratum

References (72)

1. BW Adams B Moghaddam 2001 Effect of clozapine, haloperidol, or M100907 on phencyclidine-activated glutamate efflux in the prefrontal cortex Biol Psychiatry 50 750 757
2. Y Ago S Nakamura A Baba T Matsuda 2005 Sulpiride in combination with fluvoxamine increases in vivo dopamine release selectively in rat prefrontal cortex Neuropsychopharmacology 30 43 51
3. AR Ase F Amdiss C Hebert N Huang NM van Gelder TA Reader 1999 Effects of antipsychotic drugs on dopamine and serotonin contents and metabolites, dopamine and serotonin transporters, and serotonin1A receptors J Neural Transm 106 75 105
4. O Bai J Chlan-Fourney R Bowen D Keegan XM Li 2003 Expression of brain-derived neurotrophic factor mRNA in rat hippocampus after treatment with antipsychotic drugs J Neurosci Res 71 127 131
5. RJ Baldessarini F Centorrino JG Flood SA Volpicelli D Huston-Lyons BM Cohen 1993 Tissue concentrations of clozapine and its metabolites in the rat Neuropsychopharmacology 9 117 124
6. RJ Baldessarini ER Marsh NS Kula 1992 Interactions of fluoxetine with metabolism of dopamine and serotonin in rat brain regions Brain Res 579 152 156
7. VN Barth E Chernet LJ Martin AB Need KS Rash M Morin LA Phebus 2006 Comparison of rat dopamine D2 receptor occupancy for a series of antipsychotic drugs measured using radiolabeled or nonlabeled raclopride tracer Life Sci 78 3007 3012
8. RH Belmaker 1984 The lessons of platelet monoamine oxidase Psychol Med 14 249 253
9. FP Bymaster W Zhang PA Carter J Shaw E Chernet L Phebus DT Wong KW Perry 2002 Fluoxetine, but not other selective serotonin uptake inhibitors, increases norepinephrine and dopamine extracellular levels in prefrontal cortex Psychopharmacology (Berl) 160 353 361
10. Y Chertkow O Weinreb MB Youdim H Silver 2005 The effect of chronic co-administration of fluvoxamine and haloperidol compared to clozapine on the GABA system in the rat frontal cortex Int J Neuropsychopharmacol 8 1 10
11. S Cho AM Duchemin NH Neff M Hadjiconstantinou 1999 Tyrosine hydroxylase, aromatic L-amino acid decarboxylase and dopamine metabolism after chronic treatment with dopaminergic drugs Brain Res 830 237 245
12. VZ Chong LT Young RK Mishra 2002 cDNA array reveals differential gene expression following chronic neuroleptic administration: implications of synapsin II in haloperidol treatment J Neurochem 82 1533 1539
13. WA Daniel M Syrek J Wojcikowski 1999 The influence of selective serotonin reuptake inhibitors on the plasma and brain pharmacokinetics of the simplest phenothiazine neuroleptic promazine in the rat Eur Neuropsychopharmacol 9 337 344
14. KL Davis RS Kahn G Ko M Davidson 1991 Dopamine in schizophrenia: a review and reconceptualization Am J Psychiatry 148 1474 1486
15. D Denys AA Klompmakers HG Westenberg 2004 Synergistic dopamine increase in the rat prefrontal cortex with the combination of quetiapine and fluvoxamine Psychopharmacology (Berl) 176 195 203
16. G Di Chiara A Imperato 1985 Rapid tolerance to neuroleptic-induced stimulation of dopamine release in freely moving rats J Pharmacol Exp Ther 235 487 494
17. PR Dunkley L Bobrovskaya ME Graham EI von Nagy-Felsobuki PW Dickson 2004 Tyrosine hydroxylase phosphorylation: regulation and consequences J Neurochem 91 1025 1043
18. EC Essig IC Kilpatrick 1991 Influence of acute and chronic haloperidol treatment on dopamine metabolism in the rat caudate-putamen, prefrontal cortex and amygdala Psychopharmacology (Berl) 104 194 200
19. CR Estrella C Bregonzio RJ Cabrera 2002 Differential responses in central dopaminergic activity induced by apomorphine in IPL nude rat Behav Brain Res 133 143 148
20. JM Finlay A Jakubovic DS Fu HC Fibiger 1987 Tolerance to haloperidol-induced increases in dopamine metabolites: fact or artifact? Eur J Pharmacol 137 117 121
21. V Fischer U Schmitt H Weigmann B Von Keller S Reuss C Hiemke N Dahmen 1998 Chronical haloperidol and clozapine treatment in rats: differential RNA display analysis, behavioral studies and serum level determination Prog Neuropsychopharmacol Biol Psychiatry 22 1129 1139
22. XM Gao T Hashimoto TB Cooper CA Tamminga 1997 The dose-response characteristics of rat oral dyskinesias with chronic haloperidol or clozapine administration J Neural Transm 104 97 104
23. DC Goff KK Midha O Sarid-Segal JW Hubbard E Amico 1995 A placebo-controlled trial of fluoxetine added to neuroleptic in patients with schizophrenia Psychopharmacology (Berl) 117 417 423
24. AA Grace BS Bunney H Moore CL Todd 1997 Dopamine-cell depolarization block as a model for the therapeutic actions of antipsychotic drugs Trends Neurosci 20 31 37
25. K Hakansson L Pozzi A Usiello J Haycock E Borrelli G Fisone 2004 Regulation of striatal tyrosine hydroxylase phosphorylation by acute and chronic haloperidol Eur J Neurosci 20 1108 1112
26. LM Hall GM Anderson DJ Cohen 1995 Acute and chronic effects of fluoxetine and haloperidol on mouse brain serotonin and norepinephrine turnover Life Sci 57 791 801
27. S Hartter H Wetzel E Hammes M Torkzadeh C Hiemke 1998 Serum concentrations of fluvoxamine and clinical effects. A prospective open clinical trial Pharmacopsychiatry 31 199 200
28. S Hartter H Wetzel C Hiemke 1992 Automated determination of fluvoxamine in plasma by column-switching high-performance liquid chromatography Clin Chem 38 2082 2086
29. JJ Hoo P Noldt WJ Beckermann DP Agarwal HW Goedde 1982 In vitro effect of haloperidol, chlorpromazine, imipramine and lithium on the erythrocyte catechol-O-methyltransferase Arzneimittelforschung 32 681 683
30. J Ichikawa HY Meltzer 1991 Differential effects of repeated treatment with haloperidol and clozapine on dopamine release and metabolism in the striatum and the nucleus accumbens J Pharmacol Exp Ther 256 348 357
31. K Igarashi F Kasuya M Fukui E Usuki N Castagnoli Jr 1995 Studies on the metabolism of haloperidol (HP): the role of CYP3A in the production of the neurotoxic pyridinium metabolite HPP+ found in rat brain following ip administration of HP Life Sci 57 2439 2446
32. PW Kalivas P Duffy LA DuMars C Skinner 1988 Behavioral and neurochemical effects of acute and daily cocaine administration in rats J Pharmacol Exp Ther 245 485 492
33. B Karolewicz L Antkiewicz-Michaluk J Michaluk J Vetulani 1996 Different effects of chronic administration of haloperidol and pimozide on dopamine metabolism in the rat brain Eur J Pharmacol 313 181 186
34. T Kato S Horiuchi A Togari T Nagatsu 1981 A sensitive and inexpensive high-performance liquid chromatographic assay for tyrosine hydroxylase Experientia 37 809 811
35. S Koch KW Perry FP Bymaster 2004 Brain region and dose effects of an olanzapine/fluoxetine combination on extracellular monoamine concentrations in the rat Neuropharmacology 46 232 242
36. SC Kumer KE Vrana 1996 Intricate regulation of tyrosine hydroxylase activity and gene expression J Neurochem 67 443 462
37. M Kurachi R Shibata M Murata Y Tanii 1995 Parallel development of dopamine metabolism tolerance in the rat prefrontal cortex, caudate-putamen, and amygdala following haloperidol decanoate administration Biol Psychiatry 37 487 490
38. T Kuroki HY Meltzer J Ichikawa 1999 Effects of antipsychotic drugs on extracellular dopamine levels in rat medial prefrontal cortex and nucleus accumbens J Pharmacol Exp Ther 288 774 781
39. JA Lieberman TS Stroup JP McEvoy MS Swartz RA Rosenheck DO Perkins RS Keefe SM Davis CE Davis BD Lebowitz J Severe JK Hsiao 2005 Effectiveness of antipsychotic drugs in patients with chronic schizophrenia N Engl J Med 353 1209 1223
40. HY Meltzer Z Li Y Kaneda J Ichikawa 2003 Serotonin receptors: their key role in drugs to treat schizophrenia Prog Neuropsychopharmacol Biol Psychiatry 27 1159 1172
41. H Moore AA Grace 2002 A role for electrotonic coupling in the striatum in the expression of dopamine receptor-mediated stereotypies Neuropsychopharmacology 27 980 992
42. C Moret M Briley 1992 Effect of antidepressant drugs on monoamine synthesis in brain in vivo Neuropharmacology 31 679 684
43. BP Murphy YC Chung TW Park PD McGorry 2006 Pharmacological treatment of primary negative symptoms in schizophrenia: A systematic review Schizophr Res 88 5 25
44. NK Ng HS Lee PT Wong 1999 Regulation of striatal dopamine release through 5-HT1 and 5-HT2 receptors J Neurosci Res 55 600 607
45. A Ortega-Alvaro J Gibert-Rahola JA Mico 2006 Influence of chronic treatment with olanzapine, clozapine and scopolamine on performance of a learned 8-arm radial maze task in rats Prog Neuropsychopharmacol Biol Psychiatry 30 104 111
46. J Penttila J Kajander S Aalto J Hirvonen K Nagren T Ilonen E Syvalahti J Hietala 2004 Effects of fluoxetine on dopamine D2 receptors in the human brain: a positron emission tomography study with [11C]raclopride Int J Neuropsychopharmacol 7 431 439
47. PJ Perry DD Miller SV Arndt RJ Cadoret 1991 Clozapine and norclozapine plasma concentrations and clinical response of treatment-refractory schizophrenic patients Am J Psychiatry 148 231 235
48. SC Piscitelli JA Frazier K McKenna KE Albus DR Grothe CT Gordon JL Rapoport 1994 Plasma clozapine and haloperidol concentrations in adolescents with childhood-onset schizophrenia: association with response J Clin Psychiatry 55 Suppl B 94 97
49. M Rapoport R van Reekum H Mayberg 2000 The role of the cerebellum in cognition and behavior: a selective review J Neuropsychiatry Clin Neurosci 12 193 198
50. RB Rastogi RL Singhal YD Lapierre 1982 Comparative effects of short- and long-term treatment with neuroleptics on behavioural activity as well as dopamine turnover in striatum Gen Pharmacol 13 35 40
51. B Scatton 1977 Differential regional development of tolerance to increase in dopamine turnover upon repeated neuroleptic administration Eur J Pharmacol 46 363 369
52. U Schmitt N Dahmen V Fischer H Weigmann ML Rao S Reuss C Hiemke 1999 Chronic oral haloperidol and clozapine in rats: a behavioral evaluation Neuropsychobiology 39 86 91
53. P Schulte 2003 What is an adequate trial with clozapine?: therapeutic drug monitoring and time to response in treatment-refractory schizophrenia Clin Pharmacokinet 42 607 618
54. H Silver N Aharon A Kaplan 2003 Add-on fluvoxamine improves primary negative symptoms: evidence for specificity from response analysis of individual symptoms Schizophr Bull 29 541 546
55. H Silver I Barash N Aharon A Kaplan M Poyurovsky 2000 Fluvoxamine augmentation of antipsychotics improves negative symptoms in psychotic chronic schizophrenic patients: a placebo-controlled study Int Clin Psychopharmacol 15 257 261
56. H Silver M Kushnir A Kaplan 1996 Fluvoxamine augmentation in clozapine-resistant schizophrenia: an open pilot study Biol Psychiatry 40 671 674
57. H Silver A Nassar 1992 Fluvoxamine improves negative symptoms in treated chronic schizophrenia: an add-on double-blind, placebo-controlled study Biol Psychiatry 31 698 704
58. H Silver N Shmugliakov 1998 Augmentation with fluvoxamine but not maprotiline improves negative symptoms in treated schizophrenia: evidence for a specific serotonergic effect from a double-blind study J Clin Psychopharmacol 18 208 211
59. H Silver MB Youdim 2000 MAO-A and MAO-B activities in rat striatum, frontal cortex and liver are unaltered after long-term treatment with fluvoxamine and desipramine Eur Neuropsychopharmacol 10 125 128
60. P Smid HK Coolen HG Keizer R van Hes JP de Moes AP den Hartog B Stork RH Plekkenpol LC Niemann CN Stroomer MT Tulp HH van Stuivenberg AC McCreary MB Hesselink AH Herremans CG Kruse 2005 Synthesis, structure-activity relationships, and biological properties of 1-heteroaryl-4-[omega-(1H-indol-3- yl)alkyl]piperazines, novel potential antipsychotics combining potent dopamine D2 receptor antagonism with potent serotonin reuptake inhibition J Med Chem 48 6855 6869
61. E Spina P De Domenico C Ruello N Longobardo C Gitto M Ancione AE Di Rosa AP Caputi 1994 Adjunctive fluoxetine in the treatment of negative symptoms in chronic schizophrenic patients Int Clin Psychopharmacol 9 281 285
62. T Sumiyoshi H Kido H Sakamoto K Urasaki K Suzuki N Yamaguchi H Mori K Shiba 1994 Time course of dopamine1,2 and serotonin2 receptor binding of antipsychotics in vivo Pharmacol Biochem Behav 49 165 169
63. H Tokunaga K Kudo T Imamura N Jitsufuchi Y Ohtsuka N Ikeda 1997 Plasma concentrations of antipsychotic drugs in psychiatric inpatients Nippon Hoigaku Zasshi 51 417 422
64. M Toru M Takashima 1985 Haloperidol in large doses reduces the cataleptic response and increases noradrenaline metabolism in the brain of the rat Neuropharmacology 24 231 236
65. SM Vasconcelos VS Nascimento CR Nogueira CM Vieira FC Sousa MM Fonteles GS Viana 2003 Effects of haloperidol on rat behavior and density of dopaminergic D2-like receptors Behav Processes 63 45 52
66. PC Waldmeier 1979 Analysis of the activation of dopamine metabolism by a serotonin uptake inhibitor Eur J Pharmacol 60 315 322
67. PC Waldmeier AA Delini-Stula 1979 Serotonin - dopamine interactions in the nigrostriatal system Eur J Pharmacol 55 363 373
68. PC Waldmeier L Maitre 1976 Clozapine: reduction of the initial dopamine turnover increase by repeated treatment Eur J Pharmacol 38 197 203
69. H Weigmann S Hartter S Maehrlein W Kiefer G Kramer G Dannhardt C Hiemke 2001 Simultaneous determination of olanzapine, clozapine and demethylated metabolites in serum by on-line column-switching high-performance liquid chromatography J Chromatogr B Biomed Sci Appl 759 63 71
70. DT Wong FP Bymaster LR Reid PG Threlkeld 1983 Fluoxetine and two other serotonin uptake inhibitors without affinity for neuronal receptors Biochem Pharmacol 32 1287 1293
71. G Zernig H De Wit S Telser M Nienhusmeier G Wakonigg K Sturm I Berger G Kemmler A Saria 2004 Subjective effects of slow-release bupropion versus caffeine as determined in a quasi-naturalistic setting Pharmacology 70 206 215
72. W Zhang KW Perry DT Wong BD Potts J Bao GD Tollefson FP Bymaster 2000 Synergistic effects of olanzapine and other antipsychotic agents in combination with fluoxetine on norepinephrine and dopamine release in rat prefrontal cortex Neuropsychopharmacology 23 250 262